Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)for Acute Decompensated Heart Failure37 locations incl. IrvineSponsor: Reprieve Cardiovascular, IncSex: All·Age: 22+Code: NCT06898515·Phase 3·RecruitingApply to this trial
Clenbuterol to Target DUX4 in FSHDfor Muscular Dystrophy, Facioscapulohumeral3 locations incl. Kansas CitySponsor: Jeffrey StatlandSex: All·Age: 18 - 75Code: NCT06721299·Phase 1·RecruitingApply to this trial
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesityfor Heart Failure With Preserved Ejection Fraction106 locations incl. BirminghamSponsor: AmgenSex: All·Age: 18 - 99Code: NCT07037459·Phase 3·RecruitingApply to this trial
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)for Aneurysm10 locations incl. TucsonSponsor: Stryker NeurovascularSex: All·Age: 18 - 80Code: NCT06872684·RecruitingApply to this trial
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Diseasefor Parkinsons Disease (PD)31 locations incl. Sun CitySponsor: BlueRock TherapeuticsSex: All·Age: 45 - 75Code: NCT06944522·Phase 3·RecruitingApply to this trial
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)for Cerebral Aneurysms9 locations incl. Park RidgeSponsor: Cerus Endovascular, Inc.Sex: All·Age: 18 - 75Code: NCT06693011·RecruitingApply to this trial
Clinician Satisfaction With the VERABAND™for Chronic Low-back Pain3 locations incl. La JollaSponsor: University of MichiganSex: All·Age: 18 - 85Code: NCT06080464·RecruitingApply to this trial
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasisfor Bronchiectasis80 locations incl. BirminghamSponsor: Boehringer IngelheimSex: All·Age: 12+Code: NCT06872892·Phase 3·RecruitingApply to this trial
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)for Autosomal Dominant Polycystic Kidney Disease35 locations incl. Garden GroveSponsor: Calico Life Sciences LLCSex: All·Age: 18 - 55Code: NCT06902558·Phase 2·RecruitingApply to this trial
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticityfor Multiple Sclerosis Spasticity15 locations incl. BirminghamSponsor: CelgeneSex: All·Age: 18 - 70Code: NCT06782490·Phase 2·RecruitingApply to this trial
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edemafor Macular Edema23 locations incl. ArcadiaSponsor: Boehringer IngelheimSex: All·Age: 18+Code: NCT06962839·Phase 2·RecruitingApply to this trial
Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received Intravenous Propofol Infusion Versus Inhalational Sevoflurane for General Anesthesia During Mechanical Thrombectomy in Patients Who Suffered From Acute Ischemic Strokefor Acute Ischemic Stroke Patients1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18+Code: NCT07001267·RecruitingApply to this trial
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthmafor Severe Asthma1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18 - 65Code: NCT06985225·RecruitingApply to this trial
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)for Muscular Dystrophy, Facioscapulohumeral6 locations incl. Palo AltoSponsor: University of Kansas Medical CenterSex: All·Age: 5 - 17Code: NCT06847282·RecruitingApply to this trial
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heartfor Heart FailureDrug: Empagliflozin105 locations incl. MobileSponsor: Boehringer IngelheimSex: All·Age: 18+Code: NCT06935370·Phase 3·RecruitingApply to this trial
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthmafor AsthmaDrug: PF-0727531536 locations incl. MobileSponsor: PfizerSex: All·Age: 18 - 70Code: NCT06977581·Phase 2·RecruitingApply to this trial
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilitiesfor Intellectual Disability1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18 - 35Code: NCT06961591·RecruitingApply to this trial
Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Painfor Chronic Low-back Pain1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18+Code: NCT06804551·Enrolling By Invitation
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dosefor RSV Infection81 locations incl. BirminghamSponsor: PfizerSex: All·Age: 0+·Accepts healthy volunteersCode: NCT06866405·Phase 3·RecruitingApply to this trial
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDPfor Polyneuropathy, Inflammatory Demyelinating, ChronicDrug: riliprubart3 locations incl. HomewoodSponsor: SanofiSex: All·Age: 18+Code: NCT06859099·Phase 3·Enrolling By Invitation
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)for Acute Stress Reaction9 locations incl. BirminghamSponsor: University of North Carolina, Chapel HillSex: All·Age: 18 - 55Code: NCT06636786·Phase 2·RecruitingApply to this trial
Weight Loss Management in Endometrial Cancer Survivorsfor Endometrial Cancer Survivors1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: Female·Age: 18+Code: NCT06877572·RecruitingApply to this trial
Prevail Global Studyfor Coronary Artery Disease51 locations incl. BirminghamSponsor: Medtronic VascularSex: All·Age: 18+Code: NCT06535854·RecruitingApply to this trial
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Diseasefor Parkinson Disease27 locations incl. PhoenixSponsor: Impax Laboratories, LLCSex: All·Age: 18+Code: NCT06765668·Phase 4·RecruitingApply to this trial
A Mobile App to Improve 24-Hour Movement Guideline Adherence in Preschoolersfor Healthy1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 3 - 4·Accepts healthy volunteersCode: NCT06667661·RecruitingApply to this trial
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomesfor Kidney Stone1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18+·Accepts healthy volunteersCode: NCT06576661·RecruitingApply to this trial
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)for Pulmonary Hypertension Due to Lung Diseases and Hypoxia66 locations incl. BirminghamSponsor: United TherapeuticsSex: All·Age: 18+Code: NCT06388421·RecruitingApply to this trial
Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)for Bladder Cancer2 locations incl. Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18+Code: NCT06721260·RecruitingApply to this trial
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Diseasefor Parkinson Disease45 locations incl. Sun CitySponsor: Neuron23 Inc.Sex: All·Age: 40 - 80Code: NCT06680830·Phase 2·RecruitingApply to this trial
Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.for Obesity and Overweight1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18+Code: NCT06636773·RecruitingApply to this trial
Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)for Kidney Transplant1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18+Code: NCT06640179·RecruitingApply to this trial
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitisfor Ulcerative Colitis14 locations incl. ScottsdaleSponsor: Boehringer IngelheimSex: All·Age: 18 - 80Code: NCT06636656·Phase 2·RecruitingApply to this trial
RETRO Study (RETrograde Renal Access Outcomes)for Renal Stones2 locations incl. TampaSponsor: University of Kansas Medical CenterSex: All·Age: 18+Code: NCT07071831·RecruitingApply to this trial
CARES (Comprehensive Analgesic, Recovery, and Education Support) for Surgery Trialfor Chronic Pain4 locations incl. StanfordSponsor: Stanford UniversitySex: All·Age: 18 - 75Code: NCT06027099·Phase 3·RecruitingApply to this trial
Muscle and Movement With Anti-Obesity Medicationsfor Obesity and Overweight1 location in Kansas CitySponsor: University of Kansas Medical CenterSex: All·Age: 18+Code: NCT06645470·RecruitingApply to this trial
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalusfor Normal Pressure Hydrocephalus28 locations incl. Los AngelesSponsor: CereVasc IncSex: All·Age: 60+Code: NCT06498960·RecruitingApply to this trial
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthmafor AsthmaDrug: Lunsekimig54 locations incl. SaralandSponsor: SanofiSex: All·Age: 18 - 80Code: NCT06676319·Phase 2·RecruitingApply to this trial
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfafor Myasthenia Gravis17 locations incl. San FranciscoSponsor: argenxSex: All·Age: 18+Code: NCT06298565·RecruitingApply to this trial
Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Studyfor Chronic Subdural Hematoma31 locations incl. PhoenixSponsor: The University of Texas Medical Branch, GalvestonSex: All·Age: 40 - 90Code: NCT06347796·RecruitingApply to this trial
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)for Primary Myelofibrosis13 locations incl. Palo AltoSponsor: Ajax Therapeutics, Inc.Sex: All·Age: 18+Code: NCT06343805·Phase 1·RecruitingApply to this trial